Deconstructing the Evolution of Metastasis
The Evomet research project aims to transform how cancer metastasis is understood and treated
Cancer incidence is growing alarmingly, with currently more than 3,5 million people affected by it in Europe. Metastasis causes the vast majority of cancer-related deaths. It is usually resistant to conventional therapies and can lead to the failure of vital organs. Additionally, research on the evolution of metastases, from their establishment to treatment resistance, has so far been limited.
Evomet is an Innovative Training Network which aims at unraveling how metastases work. It uses a multidisciplinary array of training initiatives and techniques that integrate cutting-edge genomic, single-cell omics, and in vivo validation strategies. Evomet’s function-centric approach to studying the metastasis process can potentially change how cancer metastasis is understood and reveal actionable therapeutic targets.
Company Details
- Employees
- 2
- Address
- Calle De Baldiri Reixac, 10, Barcelona,catalonia 08028,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://evomet-itn.eu/
- HQ
- Barcelona, Catalonia
Evomet Questions
Evomet's website is https://evomet-itn.eu/
Evomet's LinkedIn profile is https://es.linkedin.com/company/evomet
Evomet has
2 employees.
View email and phone details for 2
employees at Evomet.
Evomet's industry is
Research Services
Evomet's top competitors are
Research Institute Of Molecular Pathology (Imp),
Ludwig Cancer Research,
Zoya Health Care Private Limited,
Josep Carreras Leukaemia Research Institute (Ijc),
Automl.org,
Evomet S.r.l.,
Adaptmet,
Metal·lúrgica Martem S.l.,
Irb Barcelona,
Memorial Sloan Kettering Cancer Center.
Evomet's categories are Research Services
